Skip to main content

Table 1 Characteristics of the Study Population

From: Impact of diabetes mellitus on epithelial ovarian cancer survival

Ā 

Diabetic Patients (nĀ =ā€‰37)

Nondiabetic Patients (nĀ =ā€‰178)

P-value

Age at diagnosis (year)a

65.35ā€‰Ā±ā€‰(10.13)

61.30ā€‰Ā±ā€‰(8.87)

0.015

Follow-upa

27.97ā€‰Ā±ā€‰(13.00)

41.01ā€‰Ā±ā€‰(14.62)

<ā€‰0.001

BMIa

28.10ā€‰Ā±ā€‰(2.25)

25.47ā€‰Ā±ā€‰(1.87)

<ā€‰0.001

Paritya

4.45ā€‰Ā±ā€‰(3.06)

2.05ā€‰Ā±ā€‰(2.50)

<ā€‰0.001

Neoadjuant chemotherapyb

ā€ƒYes

3(8.1)

10(5.6)

0.563

ā€ƒNo

34(91.9)

168(94.4)

Menopausal statusb

ā€ƒPremenopausal

10(27)

83(46.6)

0.029

ā€ƒPostmenopausal

27(73)

95(53.4)

Stageb

ā€ƒI

1(2.7)

18(10.1)

0.047

ā€ƒII

3(8.1)

42(23.6)

ā€ƒIII

30(81.1)

110(61.8)

ā€ƒIV

3(8.1)

8(4.5)

Gradeb

ā€ƒ1

10(27)

107(60.1)

0.001

ā€ƒ2

15(40.5)

38(21.3)

ā€ƒ3

12(32.5)

33(18.5)

Histologyb

ā€ƒSerous

26(70.3)

103(57.9)

0.482

ā€ƒMucinous

6(16.2)

41(23)

ā€ƒEndometrioid

4(10.8)

16(9)

ā€ƒClear

1(2.7)

17(9.6)

ā€ƒTransitional

0(0)

1(0.6)

Debulking statusb

ā€ƒOptimal

14(37.8)

139(78.5)

<ā€‰0.001

ā€ƒSuboptimal

23(62.2)

37(20.9)

ā€ƒUnknown

0(0)

1(0.6)

HTN

ā€ƒYes

10(27)

28(15.7)

0.101

ā€ƒNo

27(73)

150(84.3)

  1. a: Values given as meanā€‰Ā±ā€‰SD(standard deviation)
  2. b: Values given as number (percentage)